Neurotek Information

A world where scalable mental health and human potential decision-making are grounded in objective cognitive performance intelligence — not observation, not assumption, not a single score. Our flagship product, MOXO, is a clinically validated digital attention assessment used in more than 50 countries and backed by over 190 peer-reviewed studies. Trusted by healthcare networks, clinics, and research institutions, MOXO helps professionals measure attention performance accurately and objectively - in-clinic or remotely without specialized hardware. For more than a decade, Neurotek has been advancing the science of attention and executive function assessment through continuous innovation, real-world validation, and a commitment to accessibility and inclusivity in mental-health care. Our Mission is to make cognitive assessment smarter, faster, and more accessible - empowering clinicians worldwide with scientifically validated digital tools that improve diagnostic confidence and patient outcomes.